Preview: Amgen's Earnings
Portfolio Pulse from Benzinga Insights
Amgen (NASDAQ:AMGN) is expected to report an EPS of $4.62 in its upcoming quarterly earnings on 2024-02-06. Analysts and investors are keen on whether Amgen will surpass this estimate and provide positive guidance for the next quarter. Historically, Amgen's share price has reacted to past earnings performances and guidance. Last quarter, Amgen beat the EPS estimate by $0.30, leading to a 2.01% share price increase the following day. Over the last year, Amgen shares have risen by 32.79%, with the stock trading at $323.19 as of February 02.
February 05, 2024 | 2:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Amgen is anticipated to report an EPS of $4.62 for the upcoming quarter. Positive past performance and a significant yearly share increase suggest optimism. The focus will be on whether it can beat the EPS estimate and provide favorable future guidance.
Given Amgen's history of beating EPS estimates and the subsequent positive reactions in its stock price, there is a high likelihood of a positive short-term impact if the company reports a beat and/or positive guidance again. The historical data provided shows a clear correlation between earnings performance and stock price movement, making this upcoming earnings report particularly significant.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100